“no apparent local or systemic toxicity was observed out to 140 days following topical application of STRATAGRAFT® to immunodeficient mice with an existing wound.”
✓ VerifiedFDA pharmacology/toxicology review, p. 10Source ↗
Pivotal GLP studies
Non-GLP 8+ week subchronic study NCREP.001 in 26 nude mice, single topical application, sacrificed to 140 days; retrospective tumorigenicity analyses to 421 days
“Minimum Eight Week Transdermal Subchronic Toxicity Study with STRATAGRAFT® Skin Tissue in Nude Mice”
✓ VerifiedFDA pharmacology/toxicology review, p. 6Source ↗
Route in tox
Topical application on full-thickness wound bed (single administration)
“Route of Administration (ROA) Topical application on the wound bed”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗